VERICHEM LABORATORIES EXPANDS REPORT OPTIONS FOR ITS FREE CLIA COMPLIANT CALIBRATION VERIFICATION PROGRAM

VERICHEM LABORATORIES has announced that it has expanded the available test reporting options that it offers with its Calibration Verification Data Reduction Program.

Scytek Laboratories Inc Stain Nuclei Histology Red Special Stain,Histology,Nuclear Fast Red Solution,H E,Eosin

Scytek laboratories offers special Stain, Antibodies, Hematology, Microbiology, Hematoxlyn, Nuclei Histology Red Special Stain, Histology ,Nuclear Fast Red Solution, H &E, Eosin, Cytology, Cytoplasm, Collagen, Erythrocytes, DAB Chromogen kit /Substrate Bulk Pack kit Citrate Plus (10x) HIER Solution by scytek

eClinical Solutions Launches elluminate® Clinical Trial Management System (CTMS) for Faster Drug Development

This announcement is in response to the growing need in the industry for solutions like elluminate CTMS that can automate operational data pipelines and reduce the time spent on manual data tracking processes to accelerate clinical development. ​ ​

Aalto Bio Reagents is pleased to announce the availability of the first highly reactive recombinant Rubella Spike Ectodomain (E1-E2) antigen

Kyruus Announces Significant Core Business Momentum in 2020 as it Accelerates Expansion into the Health Plan Market with Recent Acquisition

IDBS and Scitara announce a strategic partnership to integrate the Scitara Digital Lab Exchange (DLX™) platform with Polar™, IDBS’ Biopharmaceutical Lifecycle Management (BPLM) platform

THREAD and 1nHealth Partner to Optimize Participant Recruitment in Decentralized Clinical Trials

Strategic alliance will streamline patient-centric recruitment for sponsors and CROs, ultimately improving recruitment and retention outcomes in decentralized clinical trials

Dotmatics collaborates with HighRes Biosolutions to provide single software interface for lab digitalization

Integration of Dotmatics’ ELN with HighRes Biosolutions’ Cellario instrument control software will streamline experiments and workflows Scientists will be able to plan experiments and run instruments from the ELN

BioIVT Unveils COVID-19 Panel to Accelerate Vaccine-generated Immune Response Research

The panel contains serum or peripheral blood mononuclear cells (PBMCs) isolated from pre- and post-vaccination blood samples.

Antibiotic Research UK calls for clear guidance to ensure people on antibiotics do not miss out on the COVID-19 vaccine

Antibiotic Research UK (ANTRUK), the UK’s only charity focused on tackling bacterial antibiotic resistance, is urging the UK Government to publish clear national guidelines about whether people on antibiotics should have the COVID-19 vaccination.

MMS HOLDINGS JOINS DECENTRALIZED TRIALS & RESEARCH ALLIANCE (DTRA) AS A FOUNDING MEMBER TO ACCELERATE THE ADOPTION OF PATIENT-FOCUSED CLINICAL TRIALS

MMS Holdings – an award-winning, data-focused CRO – joins a historic alliance of fifty life sciences and healthcare organizations that seeks to accelerate the broad adoption of patient-focused, decentralized clinical trials and research. The “Decentralized Trials & Research Alliance (DTRA),” which launched on December 10th, 2020, plans to unite industry stakeholders, including healthcare companies, regulators, patient groups and research organizations with a singular mission to make clinical trial participation widely accessible by advancing policies, research practices, and new technologies in decentralized clinical research.

Baltimore Aircoil Company Announces HXV Hybrid Cooler

Solentim wins New Product Award at SLAS 2021

Solentim wins a New Product Award from the Society for Laboratory Automation and Screening (SLAS), annouced this week at SLAS Digital 2021. Solentim achieved this award with the launch of its new ICON™ and STUDIUS™ technologies.

ComputaBio Introduces Molecular Dynamics Analysis Services to Drug Development Scientists

ComputaBio, a US supplier of professional computational biology services, has introduced its molecular dynamics analysis services for industrial and academic scientists to expedite their drug development projects.

Lifeasible Developed Thermal Analysis Platform for Material Research

Matexcel Introduced Mechanical Environment Reliability Test Worldwide

Alfa Chemistry Launches MOF Chemicals for the Science Community

As the fastest growing class of materials in chemistry today, metal-organic frameworks (MOFs) have become ideal candidates for storage of fuels (hydrogen and methane), capture of carbon dioxide, and catalysis applications as well as many other applications. To meet the increasing market demand accompanying this trend, Alfa Chemistry has recently launched a subsidiary website, which is specially designed for supplying MOF chemicals, COFs linkers, and MOF materials.

Prime Global and Raremark form strategic partnership to transform solutions and outcomes for patients with rare diseases

Medical communications company, Prime Global, and healthcare technology company, Raremark®, announced today that they have formed a strategic partnership to transform solutions for patients with rare diseases. Together, the companies will uncover insights into the entire patient journey that will allow the creation of truly patient-centric drug development and commercialisation programs. Focusing on the needs of patients is the key to powerful communications that make a tangible difference to patient outcomes.

CluePoints’ Risk-Based Quality Management Platform Instrumental in Data Quality Oversight of COVID-19 Trials

CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Data Quality Oversight Software for clinical trials, today announced that its Risk-Based Quality Management (RBQM) platform has been critical in supporting numerous Pharmaceutical companies and CROs to interrogate data in their global COVID-19 vaccine and antiviral antibody trials to ensure data quality and integrity.

Domainex expands executive team to support ongoing growth

Domainex welcomes David Cronk to the team as its new Chief of Staff and promotes long standing team member and previous Head of Chemistry, Dr Ray Boffey, to Executive Director of Medicines Research.